BN Business News
Add your company to Business Communicator →

Finanse publiczne · 26.09.2014

Branded Prescription Drug Fee; Correction

This document contains corrections to final regulations, temporary regulations, and removal of temporary regulations (TD 9684) that were published in the Federal Register on Monday, July 28, 2014 (79 FR 43631). The final regulations provide guidance on the annual fee imposed on covered entities engaged in the business of manufacturing branded prescription drugs.

Source: Federal Register — Department of the TreasuryOpen original release →